Research and experimental development on natural sciences and engineering
CYTOVATION ASA
Operating profit
NOK −54.8m
Equity
NOK −93.3m
Incorporated
2001
Share capital
NOK 9.3m
Roles
Daglig lederLars Prestegarden
Regnskapsfører
Revisor
Styrets lederStein Christian Mohn
StyremedlemKatherine Skye Mellis
StyremedlemMartin William Dewhurst
StyremedlemOlav Hellebø
StyremedlemEllen Alla Lubman
Shareholders
This list is shortened — open the ownership graph to see them all.
| Name | Stake | Shares | Year |
|---|---|---|---|
| SANDWATER FUND I AS | 20.8% | 388009.000000 | 2025 |
| CANICA AS | 12.7% | 237157.000000 | 2025 |
| MYRLID AS | 10.7% | 200000.000000 | 2025 |
| JANDERSEN KAPITAL AS | 7.5% | 139310.000000 | 2025 |
| INNOVEST AS | 7.0% | 129886.000000 | 2025 |
| CYTOVATION ASA | 5.7% | 106357.000000 | 2025 |
| CYTO INVEST AS | 4.5% | 83746.000000 | 2025 |
| PACTUM VEKST AS | 4.3% | 80799.000000 | 2025 |
| BERGENSKANTEN AS | 3.1% | 58764.000000 | 2025 |
| INNOVEST AS | 2.6% | 47700.000000 | 2025 |
| MNG HOLDING BERGEN AS | 2.0% | 37280.000000 | 2025 |
| BAGGINS VENTURE AS | 1.8% | 33856.000000 | 2025 |
| VICAMA AS | 1.6% | 30000.000000 | 2025 |
| TIPS REAL PERFORMANCE AG | 1.4% | 27072.000000 | 2025 |
| HEALTH CARE INVEST AS | 1.4% | 26095.000000 | 2025 |
| LP-INVEST AS | 1.3% | 24052.000000 | 2025 |
| PER EYSTEIN LØNNING | 1.3% | 23994.000000 | 2025 |
| ROLF BJERKVIG | 1.3% | 23900.000000 | 2025 |
| MARIUS MASKE AS | 1.2% | 23000.000000 | 2025 |
| ZINOBER INVEST AS | 0.8% | 15000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| CYTOVATION ASA | Active | 5.7% | 106357.000000 |
| CYTOVATION ASA | Active | 0.4% | 6995.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.